812 related articles for article (PubMed ID: 24225968)
21. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
22. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
23. Translating genomic discoveries to the clinic in pediatric oncology.
Glade Bender J; Verma A; Schiffman JD
Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
[TBL] [Abstract][Full Text] [Related]
24. The state of genomic health care and cancer. Are we going two steps forward and one step backward?
Greco KE; Mahon SM
Annu Rev Nurs Res; 2011; 29():73-97. PubMed ID: 22891499
[TBL] [Abstract][Full Text] [Related]
25. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
[TBL] [Abstract][Full Text] [Related]
26. Personalized cancer therapy-leveraging a knowledge base for clinical decision-making.
Dumbrava EI; Meric-Bernstam F
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29212833
[TBL] [Abstract][Full Text] [Related]
27. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
28. Implementation of cancer next-generation sequencing testing in a community hospital.
Akkari Y; Smith T; Westfall J; Lupo S
Cold Spring Harb Mol Case Stud; 2019 Jun; 5(3):. PubMed ID: 31160354
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
Sheikine Y; Kuo FC; Lindeman NI
J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
[TBL] [Abstract][Full Text] [Related]
30. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
31. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
Mousses S; Kiefer J; Von Hoff D; Trent J
Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
[TBL] [Abstract][Full Text] [Related]
32. Toward clinical genomics in everyday medicine: perspectives and recommendations.
Delaney SK; Hultner ML; Jacob HJ; Ledbetter DH; McCarthy JJ; Ball M; Beckman KB; Belmont JW; Bloss CS; Christman MF; Cosgrove A; Damiani SA; Danis T; Delledonne M; Dougherty MJ; Dudley JT; Faucett WA; Friedman JR; Haase DH; Hays TS; Heilsberg S; Huber J; Kaminsky L; Ledbetter N; Lee WH; Levin E; Libiger O; Linderman M; Love RL; Magnus DC; Martland A; McClure SL; Megill SE; Messier H; Nussbaum RL; Palaniappan L; Patay BA; Popovich BW; Quackenbush J; Savant MJ; Su MM; Terry SF; Tucker S; Wong WT; Green RC
Expert Rev Mol Diagn; 2016; 16(5):521-32. PubMed ID: 26810587
[TBL] [Abstract][Full Text] [Related]
33. Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Walko C; Kiel PJ; Kolesar J
Am J Health Syst Pharm; 2016 Dec; 73(23):1935-1942. PubMed ID: 27864201
[TBL] [Abstract][Full Text] [Related]
34. The impact of next-generation sequencing on genomics.
Zhang J; Chiodini R; Badr A; Zhang G
J Genet Genomics; 2011 Mar; 38(3):95-109. PubMed ID: 21477781
[TBL] [Abstract][Full Text] [Related]
35. Considerations of developing an NGS assay for clinical applications in precision oncology: The NCI-MATCH NGS assay experience.
Lih CJ; Takebe N
Curr Probl Cancer; 2017; 41(3):201-211. PubMed ID: 28625332
[TBL] [Abstract][Full Text] [Related]
36. Changing Landscape of Clinical-Genomic Oncology Practice.
Trivedi H; Kling HM; Treece T; Audeh W; Srkalovic G
Acta Med Acad; 2019 Apr; 48(1):6-17. PubMed ID: 31264429
[TBL] [Abstract][Full Text] [Related]
37. Re-focusing the ethical discourse on personalized medicine: a qualitative interview study with stakeholders in the German healthcare system.
Schleidgen S; Marckmann G
BMC Med Ethics; 2013 May; 14():20. PubMed ID: 23705623
[TBL] [Abstract][Full Text] [Related]
38. Closing the gap between knowledge and clinical application: challenges for genomic translation.
Burke W; Korngiebel DM
PLoS Genet; 2015; 11(2):e1004978. PubMed ID: 25719903
[TBL] [Abstract][Full Text] [Related]
39. Assessing the Value of Next-Generation Sequencing Tests in a Dynamic Environment.
Burris HA; Saltz LB; Yu PP
Am Soc Clin Oncol Educ Book; 2018 May; 38():139-146. PubMed ID: 30231307
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
